vs
Guidewire Software, Inc.（GWRE）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Guidewire Software, Inc.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.6倍（$332.6M vs $207.3M），Guidewire Software, Inc.净利率更高（9.4% vs -62.0%，领先71.4%），Guidewire Software, Inc.同比增速更快（26.5% vs 25.9%），Guidewire Software, Inc.自由现金流更多（$-72.3M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 17.5%）
Guidewire Software是总部位于美国加利福尼亚州圣马特奥的软件企业，面向美国及全球的财产与意外伤害保险经营机构提供专业行业平台，支持险企优化业务流程、推进数字化升级，满足保险行业的各类专业化运营需求。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
GWRE vs RARE — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $332.6M | $207.3M |
| 净利润 | $31.3M | $-128.6M |
| 毛利率 | 63.0% | — |
| 营业利润率 | 5.6% | -54.7% |
| 净利率 | 9.4% | -62.0% |
| 营收同比 | 26.5% | 25.9% |
| 净利润同比 | 242.6% | 3.5% |
| 每股收益（稀释后） | $0.36 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $332.6M | $207.3M | ||
| Q3 25 | $356.6M | $159.9M | ||
| Q2 25 | $293.5M | $166.5M | ||
| Q1 25 | $289.5M | $139.3M | ||
| Q4 24 | $262.9M | $164.6M | ||
| Q3 24 | $291.5M | $139.5M | ||
| Q2 24 | $240.7M | $147.0M | ||
| Q1 24 | $240.9M | $108.8M |
| Q4 25 | $31.3M | $-128.6M | ||
| Q3 25 | $52.0M | $-180.4M | ||
| Q2 25 | $46.0M | $-115.0M | ||
| Q1 25 | $-37.3M | $-151.1M | ||
| Q4 24 | $9.1M | $-133.2M | ||
| Q3 24 | $16.8M | $-133.5M | ||
| Q2 24 | $-5.5M | $-131.6M | ||
| Q1 24 | $9.7M | $-170.7M |
| Q4 25 | 63.0% | — | ||
| Q3 25 | 65.0% | — | ||
| Q2 25 | 62.2% | — | ||
| Q1 25 | 61.9% | — | ||
| Q4 24 | 60.2% | — | ||
| Q3 24 | 64.0% | — | ||
| Q2 24 | 59.1% | — | ||
| Q1 24 | 59.1% | — |
| Q4 25 | 5.6% | -54.7% | ||
| Q3 25 | 8.3% | -106.9% | ||
| Q2 25 | 1.5% | -64.8% | ||
| Q1 25 | 4.0% | -102.6% | ||
| Q4 24 | -1.8% | -74.3% | ||
| Q3 24 | 3.5% | -94.6% | ||
| Q2 24 | -6.9% | -79.1% | ||
| Q1 24 | -5.2% | -151.9% |
| Q4 25 | 9.4% | -62.0% | ||
| Q3 25 | 14.6% | -112.8% | ||
| Q2 25 | 15.7% | -69.0% | ||
| Q1 25 | -12.9% | -108.5% | ||
| Q4 24 | 3.5% | -80.9% | ||
| Q3 24 | 5.7% | -95.7% | ||
| Q2 24 | -2.3% | -89.5% | ||
| Q1 24 | 4.0% | -156.8% |
| Q4 25 | $0.36 | $-1.28 | ||
| Q3 25 | $0.61 | $-1.81 | ||
| Q2 25 | $0.54 | $-1.17 | ||
| Q1 25 | $-0.45 | $-1.57 | ||
| Q4 24 | $0.11 | $-1.34 | ||
| Q3 24 | $0.21 | $-1.40 | ||
| Q2 24 | $-0.07 | $-1.52 | ||
| Q1 24 | $0.12 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.0B | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.5B | $-80.0M |
| 总资产 | $2.6B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $1.0B | $421.0M | ||
| Q3 25 | $1.1B | $202.5M | ||
| Q2 25 | $920.4M | $176.3M | ||
| Q1 25 | $1.2B | $127.1M | ||
| Q4 24 | $1.3B | $174.0M | ||
| Q3 24 | $1.0B | $150.6M | ||
| Q2 24 | $782.3M | $480.7M | ||
| Q1 24 | $777.6M | $112.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $398.9M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.5B | $-80.0M | ||
| Q3 25 | $1.5B | $9.2M | ||
| Q2 25 | $1.4B | $151.3M | ||
| Q1 25 | $1.3B | $144.2M | ||
| Q4 24 | $1.3B | $255.0M | ||
| Q3 24 | $1.3B | $346.8M | ||
| Q2 24 | $1.3B | $432.4M | ||
| Q1 24 | $1.3B | $140.3M |
| Q4 25 | $2.6B | $1.5B | ||
| Q3 25 | $2.7B | $1.2B | ||
| Q2 25 | $2.5B | $1.3B | ||
| Q1 25 | $2.5B | $1.3B | ||
| Q4 24 | $2.6B | $1.5B | ||
| Q3 24 | $2.2B | $1.5B | ||
| Q2 24 | $2.0B | $1.6B | ||
| Q1 24 | $2.0B | $1.3B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.30× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-67.4M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $-72.3M | $-100.8M |
| 自由现金流率自由现金流/营收 | -21.7% | -48.6% |
| 资本支出强度资本支出/营收 | 1.5% | 0.5% |
| 现金转化率经营现金流/净利润 | -2.15× | — |
| 过去12个月自由现金流最近4个季度 | $286.0M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $-67.4M | $-99.8M | ||
| Q3 25 | $244.8M | $-91.4M | ||
| Q2 25 | $32.4M | $-108.3M | ||
| Q1 25 | $86.0M | $-166.5M | ||
| Q4 24 | $-62.3M | $-79.3M | ||
| Q3 24 | $193.8M | $-67.0M | ||
| Q2 24 | $4.8M | $-77.0M | ||
| Q1 24 | $69.3M | $-190.7M |
| Q4 25 | $-72.3M | $-100.8M | ||
| Q3 25 | $241.4M | $-92.7M | ||
| Q2 25 | $31.6M | $-110.7M | ||
| Q1 25 | $85.2M | $-167.8M | ||
| Q4 24 | $-63.1M | $-79.5M | ||
| Q3 24 | $192.1M | $-68.6M | ||
| Q2 24 | $4.1M | $-79.0M | ||
| Q1 24 | $66.3M | $-193.9M |
| Q4 25 | -21.7% | -48.6% | ||
| Q3 25 | 67.7% | -58.0% | ||
| Q2 25 | 10.8% | -66.5% | ||
| Q1 25 | 29.4% | -120.5% | ||
| Q4 24 | -24.0% | -48.3% | ||
| Q3 24 | 65.9% | -49.2% | ||
| Q2 24 | 1.7% | -53.7% | ||
| Q1 24 | 27.5% | -178.2% |
| Q4 25 | 1.5% | 0.5% | ||
| Q3 25 | 1.0% | 0.8% | ||
| Q2 25 | 0.2% | 1.5% | ||
| Q1 25 | 0.3% | 1.0% | ||
| Q4 24 | 0.3% | 0.1% | ||
| Q3 24 | 0.6% | 1.2% | ||
| Q2 24 | 0.3% | 1.4% | ||
| Q1 24 | 1.2% | 3.0% |
| Q4 25 | -2.15× | — | ||
| Q3 25 | 4.71× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -6.82× | — | ||
| Q3 24 | 11.56× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 7.15× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GWRE
| Subscription | $222.7M | 67% |
| Services | $62.4M | 19% |
| Other | $33.1M | 10% |
| Support | $14.5M | 4% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
